Onivyde 43 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FCRJ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,719
Award facts
- Contract value 100% obligated
- $11,719.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,719.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of ONIVYDE 43 mg/10 ml vials. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition strategy launched on November 13, 2025. The PPV-G GEN V contract, with a ceiling value of $499,999,999 and completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. The company's established track record of supplying specialized pharmaceutical products, including oncology treatments and specialty medications, demonstrates its capability to fulfill the diverse requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCRJ0?
SPE2DR26FCRJ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FCRJ0 worth?
The government has obligated $11,719 on SPE2DR26FCRJ0.
Is contract SPE2DR26FCRJ0 an order under another contract?
Yes. SPE2DR26FCRJ0 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRJ0 competed?
The extent of competition for SPE2DR26FCRJ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award